Andere Sprachen Jointown Pharmaceutical Group Co., Ltd

Aktien

A1JCPC

CNE100000W45

600998

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 30.04.2024			% 5 Tage	% 1. Jan.
8,21 ^CNY	+1,61 %		-3,41 %	+17,12 %

29.04.	Jointown Pharma's Q1 Gewinn und Umsatz fallen um 4%	MT
29.04.	Jointown Pharmaceutical Group's 2023 Gewinn springt um 4%	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Jointown Pharma's Q1 Profit, Revenue Fall 4%	29.04.
Jointown Pharmaceutical Group's 2023 Profit Jumps 4%	29.04.
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	26.04.
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	26.04.
Jointown Pharmaceutical Sets Up Joint AI Lab with Peking University's Wuhan Campus	08.04.
Jiuzhoutong Pharmaceutical Investment Co., Ltd. announced that it expects to receive CNY 10.9100689 billion in funding from Jointown Pharmaceutical Group Co., Ltd	27.10.23
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26.10.23
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	24.08.23
Jointown Pharma's Unit Gets Nod for Registration of Acarbose Tablets	05.07.23
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	24.04.23
Nanjing IASO Biotherapeutics announced that it has received funding from Shanghai Chuanghehui Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd	13.01.23
Fujian Fukang Pharmaceutical Co., Ltd. announced that it has received funding from Shaoxing Shangyu Hangzhou Bay Economic Development Zone Holding Group Co., Ltd., Jointown Pharmaceutical Group Co., Ltd	04.01.23
Jointown Pharmaceutical Group Co., Ltd announces decision of Regulatory Authority on the transaction	13.12.22
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.	27.10.22
Jointown Pharmaceutical Group Co., Ltd's Equity Buyback announced on April 26, 2022, has expired with 36,138,098 shares, representing 1.94% for CNY 425.67 million.	25.10.22
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	24.10.22
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.	11.10.22
Jointown Pharmaceutical Group Co., Ltd announced that it expects to receive CNY 2.33 billion in funding	25.08.22
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22.08.22
Nanjing Puguang Biotechnology Co., Ltd announced that it has received $15 million in funding from Huatai Zijin Investment Co. Ltd, Nanjing XinGong Investment Group Co., Ltd, Shanghai Wenzhou Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd	11.07.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Jointown Pharmaceutical Group Co., Ltd

Aktien

A1JCPC

CNE100000W45

600998

Andere Sprachen

Filter